News & Press


New project granted

Regensburg, 2018-05-18: New project granted: The Wagner lab will be partner in the project "A therapeutic vaccine to eradicate pre-malignant HPV16 and HPV18 infection and prevent cancer" (THERIN). In cooperation with the University of Copenhagen (Peter Holst) and Sirion Biotech, vaccine vector candidates (DNA, adenovirus and MVA vectors) will be generated that carry several HPV antigens. These will be testes for immunogenicity in mice and their therapeutic potential in a non-human-primate model of papillomavirus infection. The Wagner lab contribution to the project encompasses the antigen design (protein and gene design), the generation of DNA- and MVA-vaccine-vectors and their ex vivo characterization. For more information, click here.


Upcoming Meetings
> more


We permanently offer several opportunities for students to conduct research projects in the context of `Forschungs- und Schwerpunktpraktika┬┤.
> more